Clinical Trial Update: Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS) [Phase 3]

View source ↗

Summary

Phase 3 post-marketing surveillance study evaluating carotid artery stenting with embolic protection (CASES-PMS) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Disease

Drugs mentioned

• Carotid Artery Stenting with Embolic Protection

Snippet

Sponsor: Cordis US Corp. | Conditions: Carotid Artery Disease | Phase 3 | Status: COMPLETED